The Experience Matters. Let us show you why.
Contact us today.
Clinical Trials & REMS in the Time of Corona: FDA & MHRA Advice and Guidance
Bart Cobert / Apr 09, 2020
Pharmacovigilance expert Bart Cobert discusses the FDA and MHRA guidance for non-Corona related clinical trials.
Read More
Does Rapid FDA Approval Produce Drug Safety Issues?
Bart Cobert / Mar 16, 2020
Bart Cobert gives his pharmacovigilance point of view on a recent paper on FDA approval timelines and drug safety issues.
Read More
Clintrials.gov Update
Bart Cobert / Feb 11, 2020
Bart Cobert on the importance of publishing clinical trials data and implications on pharmacovigilance.
Read More
Pharmacovigilance 2030
Bart Cobert / Dec 11, 2019
This is an interesting article looking at what PV will be in the year 2030.
Read More
FDA Draft Guidance on PMRs
Bart Cobert / Nov 24, 2019
Bart Cobert highlights the most important changes in the recently revised FDA draft guidance on PMRs.
Read More
Ranitidine – What Happened and What Do We Learn?
Bart Cobert / Oct 31, 2019
Bart Cobert explores several important points to take from the still ongoing signal and safety issue with Renitidine recall.
Read More
Video Email: Your Secret Weapon in Improving cSat
Karen Weber / Oct 23, 2019
The advantages of utilizing video email response to overcome low customer satisfaction.
Read More
Why Coupons Are Still a Powerful Strategy for Brands
Kelly Thompson / Oct 14, 2019
When it comes to driving consumer behavior, coupons continue to be a powerful force.
Read More
Going Mobile: Creating Experiences that Matter with the Avaya Mobile Experience
David Chavez / Oct 14, 2019
Read how C3i Solutions is leveraging Avaya Mobile Experience to provide better customer experience.
Read More
Vaping – A Serious Safety Signal
Bart Cobert / Oct 07, 2019
Bart Cobert discusses the major safety issue in the US on e-cigarettes and vaping.
Read More
